[Federal Register Volume 79, Number 8 (Monday, January 13, 2014)]
[Notices]
[Page 2157]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-00283]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning Measurements 
of the Inhibition of Synaptic Activity (MISA) To Detect, Study and 
Evaluate All Active Botulinum Neurotoxin Serotypes

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/851,599, entitled ``Measurements of the Inhibition of Synaptic 
Activity (MISA) to Detect, Study and Evaluate All Active Botulinum 
Neurotoxin Serotypes,'' filed on March 8, 2013. The United States 
Government, as represented by the Secretary of the Army, has rights to 
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to measurements of 
spontaneous or evoked electrical activity in networked populations of 
primary neurons or stem cell-derived neurons as a rapid, sensitive 
assay for the presence of functional botulinum neurotoxin (BoNT) in 
various matrices.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-00283 Filed 1-10-14; 8:45 am]
BILLING CODE 3710-08-P